NEWS SOURCE: Eshee Clinical Esthetic
SOMERVILLE, N.J., Sept. 23 (SEND2PRESS NEWSWIRE) — The benchmark in a new generation of anti-aging is here – E’shee Cellular Repairing Night Cream. This new skin care product is the culmination of cutting-edge research in stem cell technology and anti-aging medicine. It utilizes the most advanced technology in skin care.
E’shee Cellular Repairing Night Cream represents the newest and most-advanced formulation to treat aging and photo-damaged skin. This elegant and exclusive formula contains human Acidic Fibroblast Growth Factor, also known as FGF 1 (or aFGF) and Human Identical Tissue Inhibitor (PEPHA-TIMP2) – the latest in patented human fibroblast cloning process and tissue-engineering technology.
Collagen and elastin fibers, immersed in glycosaminoglycans, are what comprise the dermis’ connective tissue. And, these three components all originate from fibroblasts.
Researchers have found that fibroblast stimulation can promote continued synthesis of collagen, elastin and hyaluronic acid, thus slowing the aging process.
“This is where human fibroblast growth factors in topical application products can help,” says Nataly Giter, the company’s founder. “Products such as E’shee’s Cellular Repairing Night Cream are groundbreaking and produce never-seen-before end results.”
FGF 1 also plays an important role in tissue repair and wound healing. It works as a catalyst and skin cells grow 10 to 20 times faster when compared to other professional skin care products.
“We are proud to be the only skin care company in the U.S. to use this ingredient in our skin care products,” adds Giter.
Another revolutionary ingredient used in E’shee Cellular Repairing Night Cream is PEPHA®-TIMP. This works to increase firmness; to protect fibers and cell membranes; and to restore the dermal tissue.
In fact, after using E’shee skin care products, 98 percent of patients who participated in an ongoing clinical study reported that their skin condition was improved after only four weeks.
About E’shee Clinical Esthetic:
Launched in 2009 by Nataly Giter, a skin care professional who has worked with many of the world’s professional product lines for two decades, Giter sought to develop more effective skin care products. Through research and practical experience, she learned about the ingredients that work best and became associated with Dr. Chiu, a professor from Ohio University. Dr. Chiu is the first global pioneer to clone the human FGF 1 gene.
Together with Dr. Chiu, his team of chemists and their combined connections to industry professionals, they utilized FGF 1 to create an extraordinary anti-aging product line, using 99 percent pure FGF 1 peptide – the best quality in the world.
For more information on E’shee Clinical Esthetic visit www.esheeesthetic.com or visit the company’s blog at www.esheeesthetic.com/wordpress/.
News issued by: E’shee Clinical Esthetic
Original Image: https://www.send2press.com/wire/images/10-0923-eshee_72dpi.jpg
# # #
Original Story ID: (6309) :: 2010-09-0923-004
Original Keywords: FGF 1 gene, anti-aging, stem cell technology, skin care products, E’shee Clinical Esthetic, fibroblast growth factor, FGF1, collagen, elastin, anti-wrinkle, professional skin care products, Human Identical Tissue Inhibitor, PEPHA-TIMP2, Nataly Giter E’shee Clinical Esthetic Somerville New Jersey SOMERVILLE, N.J.
Alternate Headline: New Skin Care Product: E’shee Cellular Repairing Night Cream
NEWS ARCHIVE NOTE: this archival news content, issued by the news source via Send2Press Newswire, was originally located in the Send2Press® 2004-2015 2.0 news platform and has been permanently converted/moved (and redirected) into our 3.0 platform. Also note the story “reads” counter (bottom of page) does not include any data prior to Oct. 30, 2016. This press release was originally published/issued: Thu, 23 Sep 2010 07:59:42 +0000
NEWS SOURCE: Eshee Clinical Esthetic | Published: 2010-09-23 07:59:42
IMPORTANT NOTICE FOR ARCHIVAL CONTENT ABOVE: The above archival press release content was issued on behalf of the noted "news source" who provided the content (text and image[s]) and is solely responsible for its accuracy. Links may not work if very old; use such with caution. Send2Press does not represent the "news source" in any capacity. For questions about this content contact the company/person mentioned directly. To report fraud or illegal material, or DMCA complaints, please contact Send2Press via our main site (any such complaints must be made in writing, not by phone).
